Evidence map›Paper›PMID 26359185›Full record

ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2016

Association of 25-hydroxyvitamin D with areal and volumetric measures of bone mineral density and parathyroid hormone: impact of vitamin D-binding protein and its assays.

T O Jemielita, M B Leonard, J Baker, S Sayed, B S Zemel, J Shults, R Herskovitz, M R Denburg

Open access · greenAbstract readComparative StudyMulticenter Study
In one paragraph

Article in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 56 citations in OpenAlex.

  1. Trial
  2. Effects of Supplemental Vitamin D on Bone Health Outcomes in Women and Men in the VITamin D and OmegA-3 TriaL (VITAL).Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2020
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Clinical Usefulness of Bioavailable Vitamin D and Impact ofInternational journal of endocrinology · 2019
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

T O JemielitaPerelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
M B LeonardStanford University School of Medicine, Stanford, CA, USA.
J BakerPerelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
S SayedThe Children's Hospital of Philadelphia, Philadelphia, PA, USA.
B S ZemelThe Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, 34th Street and Civic Center Blvd, Philadelphia, PA, 19104, USA.
J ShultsThe Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, 34th Street and Civic Center Blvd, Philadelphia, PA, 19104, USA.
R HerskovitzThe Children's Hospital of Philadelphia, Philadelphia, PA, USA.
M R DenburgThe Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, 34th Street and Civic Center Blvd, Philadelphia, PA, 19104, USA. denburgm@email.chop.edu.
Children's Hospital of Philadelphia · USUniversity of Pennsylvania · USPhiladelphia VA Medical Center · USStanford University · US

Funding

Structural Bone Disease in Chronic Renal InsufficiencyR01DK064966 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI LEONARD, MARY BETH · 2003 to 2007
$2.7M
Renal &Urologic Biostatistics Training GrantT32DK060455 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI SHULTS, JUSTINE · 2003 to 2019
$1.9M
Patient Oriented Research in Vitamin D Deficiency in CKDK24DK076808 · NIDDK · STANFORD UNIVERSITY · PI LEONARD, MARY BETH · 2007 to 2016
$1.7M
Vitamin D Deficiency in Glomerular DiseaseK23DK093556 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI DENBURG, MICHELLE · 2012 to 2016
$858k
NIDDK NIH HHS K23 DK093556NIDDK NIH HHS K23DK093556NIDDK NIH HHS K24 DK076808NIDDK NIH HHS R01 DK064966NIDDK NIH HHS R01DK064966NIDDK NIH HHS T32 DK060455NIDDK NIH HHS T32DK060455
6 · The paper itself

Abstract

unlabelledA comparison of the association of different forms of 25-hydroxyvitamin D [25(OH)D] with parathyroid hormone (PTH) and with areal and volumetric bone mineral density (BMD) demonstrated that bioavailable and free 25(OH)D do not provide a better index of vitamin D status in terms of bone health compared to total 25(OH)D.

introductionThis study aims to compare measures of vitamin D-binding protein (DBP) using a monoclonal versus polyclonal ELISA and assess correlations of total versus estimated free and bioavailable 25(OH)D with BMD and PTH concentrations.

methodsDXA and peripheral quantitative CT (pQCT) scans were obtained in 304 adults (158 black, 146 white), ages 21-80 years. Free and bioavailable 25(OH)D were calculated from total 25(OH)D, DBP, and albumin concentrations. Multivariable linear regression with standardized beta coefficients was used to evaluate associations of bone measures and PTH with total, free, and bioavailable 25(OH)D.

resultsMeasures of DBP obtained using a monoclonal versus polyclonal ELISA were not correlated (r s = 0.02, p = 0.76). Free and bioavailable 25(OH)D based on the polyclonal assay were lower in black versus white participants (p < 0.0001); this race difference was not evident using the monoclonal assay. Adjusted for age, sex, calcium intake, and race, all forms of 25(OH)D were negatively associated with PTH, but the absolute coefficient was greatest for total 25(OH)D (-0.34, p < 0.001) versus free/bioavailable 25(OH)D (-0.18/-0.24 depending on DBP assay, p ≤ 0.003). In analyses stratified on race, none of the measures of 25(OH)D were associated with BMD across DXA and pQCT sites.

conclusionsThe monoclonal versus polyclonal ELISA yielded highly discrepant measures of DBP, particularly among black individuals, likely related to established race differences in DBP polymorphisms. Contrary to prior studies, our findings indicate that using DBP to estimate bioavailable and free 25(OH)D does not provide a better index of vitamin D status in terms of bone health.

Indexed as

AdultAgedAged, 80 and overAnthropometryBiological AvailabilityBiomarkersBlack or African AmericanBone DensityCalcium, DietaryEnzyme-Linked Immunosorbent AssayFemaleHumansMaleMiddle AgedParathyroid HormoneUnited States25-hydroxyvitamin DBiomarkersCalcium, DietaryParathyroid HormoneVitamin DVitamin D-Binding ProteinBone mineral densityParathyroid hormoneVitamin DVitamin D-binding protein

Identifiers

PMID26359185
PMCPMC4924926
OpenAlexW2208984081

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.